Skip to main navigation Skip to search Skip to main content

Patient-Preferences Favoring Treatment Discontinuation Are Reduced with Vedolizumab and Ustekinumab Compared with TNF Antagonists in Inflammatory Bowel Disease

  • Anand Kumar
  • , Emilie S. Kim
  • , Philip Kozan
  • , Vinita Jacob
  • , Randy S. Longman
  • , Ellen J. Scherl
  • , Robert J. Battat
  • , Dana J. Lukin

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Patient-Preferences Favoring Treatment Discontinuation Are Reduced with Vedolizumab and Ustekinumab Compared with TNF Antagonists in Inflammatory Bowel Disease'. Together they form a unique fingerprint.
Sort by

Keyphrases

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology